Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
22.7%
% of WDNA's 91 holdings also in BBP
32.8%
% of BBP's 65 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
SAREPTA THERAPEUTICS INC | 1.7% | 1.7% | 1.7% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.7% | 1.6% | 1.6% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 1.5% | 1.5% |
|
VERTEX PHARMACEUTICALS INC | 1.6% | 1.5% | 1.5% |
|
UNITED THERAPEUTICS CORP | 1.5% | 1.7% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BBP
|
TWIST BIOSCIENCE CORP. | 4.3% |
 |
NOVOZYMES A/S-B SHARES | 2.7% |
|
FATE THERAPEUTICS INC | 2.2% |
|
NATERA INC | 2.2% |
|
VERICEL CORPORATION | 2.1% |
|
ELI LILLY & CO | 2.1% |
|
MYRIAD GENETICS INC | 1.4% |
|
DANAHER CORP | 1.4% |
|
BEAM THERAPEUTICS, INC. | 1.4% |
|
STOKE THERAPEUTICS, INC. | 1.4% |
WDNA Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.4% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% |
|
ACADIA PHARMACEUTICALS INC | -1.9% |
|
BIOCRYST PHARMACEUTICALS INC | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |
|
ADMA BIOLOGICS, INC. | -1.8% |